TCTR20200730003已完成3 期
Sentinel lymph node biopsy after neoadjuvant treatment of breast cancer using blue dye, radioisotope, and indocyanine green : preliminary report prospective cohort study
Department of surgery Faculty of medicine Ramathibodi Hospital , Mahidol university , Bangkok , Thai0 个研究点目标入组 21 人开始时间: 2020年7月30日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 10 Years 至 90 Years（—）
- 性别
- All
入选标准
- •Eligible patients were those with locally advanced breast cancer (T2â€4, N1â€2) who received neoadjuvant treatment, with tissue pathology confirmed carcinoma
排除标准
- •Patients who had surgical biopsy or surgery that involved the axillary regions, and those with a history of allergy to ICG, isosulfan blue, or radioisotope were excluded from the study.
研究者
相似试验
尚未招募
3 期
Comparison of Fluorescein plus blue dye and blue dye alone in sentinel lymph node biopsy of breast cancer patients after neoadjuvant chemotherapyCTRI/2020/10/028337AIIMS Jodhpur
已完成
不适用
Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast CancerBreast CancerInvasive Breast CancerNCT00909441Centre hospitalier de l'Université de Montréal (CHUM)153
进行中（未招募）
1 期
Sentinel lymph node biopsy in patients with parotid gland carcinoma using a combination of 99mTc-nanocolloid and 68Ga-tilmanocept PET/CT: A feasibility study. (SNparotis)Carcinoma of the parotid glandMedDRA version: 21.1Level: LLTClassification code: 10026329Term: Malignant neoplasm of parotid gland Class: 10029104CTIS2024-514233-37-00niversitair Medisch Centrum Utrecht10
招募中
不适用
Sentinel lymph node biopsy for early stage cervical cancer.cervical cancerJPRN-UMIN000029282Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital50
招募中
不适用
Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma. A multicentre observational study.Vulvar cancerNL-OMON54845Erasmus MC, Universitair Medisch Centrum Rotterdam243